Travere Therapeutics, Inc. (0001438533) (Filer) — SEC 8-K Filing
Travere Therapeutics
May 11, 2026

Channel-specific outreach playbooks for deal origination.
Comparison posts, methodology, and analysis from the Tentt team.
Monthly market reports on M&A and private equity activity.
Free calculators for M&A, lending, and deal analysis.
Origination in the Age of AI.
Infosys has signed a definitive agreement to acquire Optimum Healthcare IT for up to $465 million in an all-cash transaction. The deal includes upfront payments and earnouts and will exclude management incentives and retention bonuses.
Infosys will acquire 100% of Optimum Healthcare IT’s equity. Optimum Healthcare IT is a US-based healthcare digital transformation and consulting firm founded in 2012, focused on clinical and operational transformation for provider organizations. The transaction is expected to close in the first quarter of FY2027, subject to regulatory approvals and other closing conditions.
Infosys said the acquisition will deepen its provider-segment presence and expand client access to Infosys Topaz, Infosys Cobalt, and related cloud, cybersecurity, infrastructure, and application transformation services.
Powered by Tentt
Tentt builds and operates managed deal origination services for PE firms, M&A advisors, and commercial lenders. We map the target universe, monitor signals, and execute outreach — white-labelled to your firm.
Travere Therapeutics
May 11, 2026
Pharvaris
May 11, 2026
Partner Therapeutics→Bizengri (bispecific antibody)
May 11, 2026
The Surgery Center of Southern Oregon
May 11, 2026
Mobia Medical
May 11, 2026